drugset / Trial / NCT05340205

Blood Loss During Cesarean Delivery in Placenta Previa Patients

NCT05340205

Phase 4 Completed 81 enrolled Cairo University
RandomizedParallel-groupOpen-labelPrevention

Summary

To compare the efficacy and safety profile of intravenous tranexamic acid versus intrauterine misoprostol in reducing the blood loss during and after cesarean delivery in pregnant women diagnosed with placenta previa

Timeline

Start
2022-05-04
Primary completion
2022-12-15
Completion
2023-01-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 400 ug Other
Comparator Tranexamic Acid Small molecule 1 g Intravenous
Comparator Oxytocin Peptide 20 iu Intravenous

Indications